1. Home
  2. FEMY vs ATCX Comparison

FEMY vs ATCX Comparison

Compare FEMY & ATCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$3.87

Market Cap

21.9M

Sector

Health Care

ML Signal

HOLD

ATCX

Atlas Critical Minerals Corporation Common Stock

N/A

Current Price

$3.80

Market Cap

21.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FEMY
ATCX
Founded
2004
2016
Country
United States
Brazil
Employees
N/A
13
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.9M
21.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FEMY
ATCX
Price
$3.87
$3.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$5.50
$13.75
AVG Volume (30 Days)
1.2M
21.1K
Earning Date
05-08-2026
03-16-2023
Dividend Yield
N/A
N/A
EPS Growth
44.71
N/A
EPS
N/A
N/A
Revenue
$2,293,313.00
N/A
Revenue This Year
$105.16
$827,667.00
Revenue Next Year
$200.23
$166.45
P/E Ratio
N/A
N/A
Revenue Growth
40.77
N/A
52 Week Low
$0.29
$3.50
52 Week High
$6.29
$14.01

Technical Indicators

Market Signals
Indicator
FEMY
ATCX
Relative Strength Index (RSI) 69.85 39.78
Support Level $0.47 N/A
Resistance Level $6.29 $5.62
Average True Range (ATR) 0.41 0.37
MACD 0.18 0.01
Stochastic Oscillator 62.41 36.71

Price Performance

Historical Comparison
FEMY
ATCX

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About ATCX Atlas Critical Minerals Corporation Common Stock

Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.

Share on Social Networks: